Biomedical prevention: what is the current status?

1. Faurci AS, Folkers GK. Investing to meet the scientific challenges of HIV/AIDS. Health Affairs. 2009; 28: 1629-41.10.1377/hlthaff.28.6.1629Search in Google Scholar

2. Rotheram-Borus MJ, Swendeman D, Chovmnick G. The past, present and future of HIV prevention: Integrating behavioral, biomedical and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009; 5:143-67.10.1146/annurev.clinpsy.032408.153530Open DOISearch in Google Scholar

3. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005; 2:e298.10.1371/journal.pmed.0020298Search in Google Scholar

4. Bailey RC, Moses S, Parker CB, Argot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007; 369:643-56.10.1016/S0140-6736(07)60312-2Search in Google Scholar

5. Gray RH, Kogozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet. 2007; 369:657-66.10.1016/S0140-6736(07)60313-4Search in Google Scholar

6. Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009; 68:740-48.10.1016/j.socscimed.2008.11.019Open DOISearch in Google Scholar

7. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cellmediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, testof- concept trial. Lancet. 2008; 372:1881-93.10.1016/S0140-6736(08)61591-3Search in Google Scholar

8. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomized, double-blind, placebo-controlled trial. Lancet. 2008; 372:1977-87.10.1016/S0140-6736(08)61842-5Search in Google Scholar

9. Padian S, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007; 370:251-61.10.1016/S0140-6736(07)60950-7Search in Google Scholar

10. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 371:2109-19.10.1016/S0140-6736(08)60920-4Search in Google Scholar

11. Doyle A, Ross D, Maganja K, Changalucha J, Hayes R, MEMA kwa Vijana Trial Team . Long-term impact of a behavioral change intervention on HIV, STI, knowledge, attitudes, and reported sexual behaviors among young people in rural Mwanza, Tanzania: results of a community randomized trial. Presented at 16th Conference on Retroviruses and Opportunistic Infections; Montreal, Canada; Feb 8-11, 2009. Search in Google Scholar

12. Hillier SL, Moench T, Shattock R, Black R, Reichelderfer P, Veronese F, et al. In vitro and in vivo: the story of nonoxynol-9. J Acquir Immune Defic Syndr. 2005; 39: 1-8.10.1097/01.qai.0000159671.25950.74Search in Google Scholar

13. Microbicides Development Program. HIV prevention gel PRO 2000 proven ineffective. MDP 301 Press Statement Final 111209. December 14, 2009.Search in Google Scholar

14. Grosskurth H, Mosah F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually ttransmitted diseases on DHIV infection in rural Tanzania: randomized controlled trial. Lancet. 1995; 346:530-6.10.1016/S0140-6736(95)91380-7Search in Google Scholar

15. Gray R, Wawer MJ. Randomized trails of HIV prevention. Lancet. 2007; 370:200-1. 10.1016/S0140-6736(07)61058-7Search in Google Scholar

16. Freeman E, Weiss H, Glynn JR, Cross PL, Whitworth J, Hayes RJ, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006; 20:73-83.10.1097/01.aids.0000198081.09337.a7Open DOISearch in Google Scholar

17. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, MUgeye K, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. New Engl J Med. 2008; 358:1560-71.10.1056/NEJMoa0800260Search in Google Scholar

18. Dickson NP, van Roode T, Herbison P, Paul C. Circumcision and risk of sexually transmitted infections in a birth cohort. J Pediatr. 2008; 152: 383-87. 10.1016/j.jpeds.2007.07.044Search in Google Scholar

19. Templeton DJ, Jin F, Prestage GP, Donovan B, Imrie JC, Kippax SC, et al. Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia. J Infect Dis. 2009; 200:1813-19.10.1086/648376Search in Google Scholar

20. Pozniak A. Post-exposure prophylaxis for sexual exposure to HIV. Curr Opin Infect Dis. 2004; 17:39-40.10.1097/00001432-200402000-00007Search in Google Scholar

21. The EXPLORE Study Team. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004; 364:41-50.10.1016/S0140-6736(04)16588-4Search in Google Scholar

22. Sherman SG, Sutcliffe C, Srirojn B, Latkin CA, Aramratanna A, Celentano DD. Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. Soc Sci Med. 2009; 68:69-79.10.1016/j.socscimed.2008.09.061280079318986746Open DOISearch in Google Scholar

23. NIMH Collaborative HIV/STD Prevention Trial Group. Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS. 2007; Suppl 2:S91-8.10.1097/01.aids.0000266461.33891.d017413268Search in Google Scholar

24. Crepaz N, Lyles CM, Wolitski RJ, Passin WF, Rama SM, Herbst JH et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006; 20:143-57.10.1097/01.aids.0000196166.48518.a016511407Open DOISearch in Google Scholar

25. Semaan S, Des Jarlais DC, Sogolow E, Johnson W, Hedges L, Ramirez G, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002; 30(Suppl 1):S73-93.10.1097/00042560-200207011-00008Search in Google Scholar

26. Neumann MS, Johnson WD, Semaan S, Flores SA, Peersman G, Hedges LV, et al. Review and metaanalysis of HIV prevention intervention research for heterosexual adult populations in the United States. J Acquir Immune Defic Syndr. 30(Suppl 1):S106-17.10.1097/00042560-200207011-00010Search in Google Scholar

27. Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP, SHARP Research Team. Behavioral HIV risk reduction among people who inject drugs: metaanalytic evidence of efficacy. J Subst Abuse Treat. 2006; 31:163-71.10.1016/j.jsat.2006.04.002245299216919744Open DOISearch in Google Scholar

28. Herbst JH, Sherba JT, Crepaz N, Deluca JB, Zohrabyan L, Stall RD, et al. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. 2005; 39:228-41.Search in Google Scholar

29. Celentano DD, Beyrer C (Eds). Public Health Aspects of HIV/AIDS in Low and Middle Income Countries: Epidemiology, Prevention and Care. New York: Springer, 2008.Search in Google Scholar